SCHEMBL7065729

SCHEMBL7065729

CCOC(=O)C(C)(C)[C]=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP4F2 P78329 3/20 0.42
CYP4A11 Q02928 3/20 0.42
ALDH1A1 P00352 3/20 0.42
PKM P14618 3/20 0.40
MMP8 P22894 2/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
THRB P10828 1/20 0.38
ABCB11 O95342 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL535883 0.79 MEN1 (0.52) MEN1KMT2ACYP4F2CYP4A11ALDH1A1
SCHEMBL20136923 0.79 CYP4F2 (0.46) MEN1KMT2ACYP4F2CYP4A11ALDH1A1
SCHEMBL11419217 0.75 ALDH1A1 (0.46) MEN1KMT2ACYP4F2CYP4A11ALDH1A1
SCHEMBL7763887 0.74 CYP4F2 (0.46) MEN1KMT2ACYP4F2CYP4A11ALDH1A1
SCHEMBL2036323 0.74 ALDH1A1 (0.50) MEN1KMT2ACYP4F2CYP4A11ALDH1A1
SCHEMBL1562023 0.74 ALDH1A1 (0.50) MEN1KMT2ACYP4F2CYP4A11ALDH1A1
SCHEMBL1785998 0.74 ALDH1A1 (0.50) MEN1KMT2ACYP4F2CYP4A11ALDH1A1
SCHEMBL126096 0.74
SCHEMBL7064864 0.73 CYP4F2 (0.43) MEN1KMT2ACYP4F2CYP4A11ALDH1A1
SCHEMBL18843249 0.73 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216258-A1 Condensed heterocylic compounds and herbicides containing them as active ingredients SUMITOMO CHEMICAL COMPANY, LIMITED 2003-11-20 US disclosed
US-6586368-B1 Benzofuran derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-07-01 US disclosed
EP-1112268-A1 CONDENSED HETEROCYCLIC COMPOUNDS AND HERBICIDES CONTAINING THEM SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2001-07-04 EP disclosed
WO-2000015633-A1 CONDENSED HETEROCYLIC COMPOUNDS AND HERBICIDES CONTAINING THEM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216258-A1 Condensed heterocylic compounds and herbicides containing them as active ingredients CBR3, CBR1, HAAO MEN1 4239/4885KMT2A 565/4885CYP4F2 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.